...Although Takeda's focus on IBD isn't new - the company markets Entyvio vedolizumab and has TAK-114...

...Natrogen Therapeutics granted Takeda exclusive, worldwide rights to develop and commercialize Natura-alpha . Takeda also received...
...regulatory and sales milestones. The company is also eligible for an undisclosed option exercise fee. Natura-alpha...

...York, N.Y.) granted Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) exclusive, worldwide rights to develop and commercialize Natura-alpha...
...regulatory and sales milestones. The company is also eligible for an undisclosed option exercise fee. Natura-alpha...